Folkehelseinstituttet
Not a member yet
10872 research outputs found
Sort by
Risks posed by managed honey bees (Apis mellifera) to wild pollinators in Norway
Get PDFacceptedVersio
Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study
Get PDFpublishedVersio
Guidance on the scientific requirements for a notification and application for authorisation of traditional foods from third countries in the context of Regulation (EU) 2015/2283
Get PDFpublishedVersio
Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial
Get PDFpublishedVersio
Cost-effectiveness of robot assisted surgery for prostate cancer
Get PDFMenn med prostatakreft i tidlig fase, blir ofte behandlet med kirurgisk fjerning av prostata og sædblære. Denne teknikken heter prostatektomi og kan utføres med robotassistert, eller med åpen teknikk. Robotassistert teknikk er mest vanlig i Norge i dag. Vi har evaluert i hvilken grad robotassistert prostatektomi oppfyller prioriteringskriteriene for den norske helsetjenesten; alvorlighet, ressurs og nytte. Nytte kan også omtales som helsegevinst for pasient. Vi har samlet informasjon om kostnader fra ulike sykehus, fra Helse Sør-Øst RHF og fra den publiserte litteraturen. Basert på funnene i vår systematiske oversikt, har vi lagt til grunn en relativ risiko reduksjon i dødelighet på 27% (HR 0,73, 95 % KI 0,65-0,81) ved bruk av robot assistert teknikk sammenlignet med åpen kirurgi. I absolutte tall, betyr dette at blant menn på 65 år vil det forekomme 24 færre dødsfall per 10 000 opererte det første året etter operasjon. Kostnadseffektivitet er analysert ved bruk av en enkel helseøkonomisk modell. For menn på 65 år: • Medfører prostatakreft et abslotutt prognosetap på 4,1 gode leveår (QALY). • Resulterer robotassistert teknikk i en merkostnad på NOK 43 347 fra et helsetjenesteperspektiv og en helsegevinst på 0,1526 153 QALY, hvilket gir en ICER på NOK 284 063/QALY. For menn på 70 år, medfører prostatakreft et absolutt prognosetap på 3,524 gode leveår (QALY). Denne lavere alvorligheten impliserer også en lavere alternativkostnad enn for 65 åringene. Helsegevinsten blir imidertid også noe større 0,206 QALY, hvilket gir en lavere ICER NOK 210 223/QALY. Konklusjon på kostnadseffektivitet avhenger av effekt av robotassistert teknikk på dødelighet.publishedVersio
The total consumption model applied to gambling: an analysis of gambling accounts records in Norway
Get PDFpublishedVersio
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
Get PDFpublishedVersio
Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024
Get PDFpublishedVersio
Prevalence and predictors of self-reported hearing aid use and benefit in Norway: the HUNT study
Get PDFBackground Knowledge on hearing aid use and benefit is important to ensure appropriate and effective treatment. We aimed to assess prevalence and predictors of hearing aid use and benefit in Norway, as well as possible birth cohort changes. Methods We analyzed two large cross-sectional, population-based hearing surveys of 63,182 adults in 1996–1998 and 2017–2019 (the HUNT study). We used multivariable regression models to examine independent predictors of hearing aid use and benefit, including demography, hearing-related variables, known risk factors for hearing loss and birth cohort. Results The nationally weighted hearing aid use in the adult population increased from 4.2% in 1997 to 5.8% in 2018. The use among individuals with disabling hearing loss (≥ 35 dB HL) increased from 46.3% to 64.4%. Most users reported some (47%) or great (48%) help from their hearing aids. In addition to the level of hearing loss and birth cohort, factors associated with hearing aid use included lower age, tinnitus, childhood-onset hearing loss, higher education, marriage, having children, being exposed to occupational noise or impulse noise, recurrent ear infections, and head injury. In addition to the level of hearing loss, factors related to hearing aid benefit included younger age, female gender, and higher income. Being bothered by tinnitus reduced the benefit. Conclusion Our study shows an increase in self-reported hearing aid usage over time in Norway, with lower adoption rates and perceived benefits observed among the elderly. The results suggest that having a spouse and children positively influences the adoption of hearing aids. These findings emphasize the necessity of customized strategies to address demographic disparities and the need for innovative enhancements in hearing rehabilitation programs.Prevalence and predictors of self-reported hearing aid use and benefit in Norway: the HUNT studypublishedVersio